Celltrion Inc Placement - Shorter Lockup Period Will Be an Overhang for Share Price
Ion Investment (Temasek) is looking to sell about 3.4m shares in Celltrion Inc (068270 KS) in an accelerated bookbuild worth approximately US$740m....
502 Views
Celltrion: Understanding Inflectra's U.S. Challenges
Celltrion Inc (068270 KS) 's Inflectra (biosimilar of Remicade marketed in the U.S.) has struggled to gain a foothold in the market since its...
614 Views
Close Long/Short on Celltrion/Celltrion Healthcare: Market Mood on Placement Is Surprisingly Mild
Damage wasn't too harsh on Celltrion Healthcare (091990 KS). Both local institutions and foreign investors seem to have been much milder this time...
463 Views
Celltrion Healthcare Placement: Two Mitigating Factors, Short Healthcare But Long Celltrion
It is quite clear that Celltrion Healthcare (091990 KS) didn't do well in the previous placement (by Temasek) back on Mar 6. The price...
791 Views
Celltrion Healthcare Placement: Weigh Down from FDA Uncertainty and Placement Overhang
Celltrion Healthcare's shareholder, One Equity Partners, is selling USD 355 million of shares via a secondary placement today. This is the first...
477 Views